Literature DB >> 29499369

The eosinophil: For better or worse, in sickness and in health.

Bruce S Bochner1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29499369      PMCID： PMC6087501          DOI： 10.1016/j.anai.2018.02.031

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  72 in total

1.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

2.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

Authors:  Amy D Klion; Pierre Noel; Cem Akin; Melissa A Law; D Gary Gilliland; Jan Cools; Dean D Metcalfe; Thomas B Nutman
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

Review 3.  Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.

Authors:  Alain M Schoepfer; Alex Straumann; Ekaterina Safroneeva
Journal:  Gastrointest Endosc Clin N Am       Date:  2017-10-07

4.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

5.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Authors:  Marc E Rothenberg; Amy D Klion; Florence E Roufosse; Jean Emmanuel Kahn; Peter F Weller; Hans-Uwe Simon; Lawrence B Schwartz; Lanny J Rosenwasser; Johannes Ring; Elaine F Griffin; Ann E Haig; Paul I H Frewer; Jacqueline M Parkin; Gerald J Gleich
Journal:  N Engl J Med       Date:  2008-03-16       Impact factor: 91.245

Review 6.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

7.  Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Authors:  Sally Wenzel; Mario Castro; Jonathan Corren; Jorge Maspero; Lin Wang; Bingzhi Zhang; Gianluca Pirozzi; E Rand Sutherland; Robert R Evans; Vijay N Joish; Laurent Eckert; Neil M H Graham; Neil Stahl; George D Yancopoulos; Mariana Louis-Tisserand; Ariel Teper
Journal:  Lancet       Date:  2016-04-27       Impact factor: 79.321

Review 8.  Eosinophil trafficking in allergy and asthma.

Authors:  Helene F Rosenberg; Simon Phipps; Paul S Foster
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

Review 9.  Functions of tissue-resident eosinophils.

Authors:  Peter F Weller; Lisa A Spencer
Journal:  Nat Rev Immunol       Date:  2017-09-11       Impact factor: 53.106

10.  Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Authors:  Nicola A Hanania; Michael Noonan; Jonathan Corren; Phillip Korenblat; Yanan Zheng; Saloumeh K Fischer; Melissa Cheu; Wendy S Putnam; Elaine Murray; Heleen Scheerens; Cecile T J Holweg; Romeo Maciuca; Sarah Gray; Ramona Doyle; Dana McClintock; Julie Olsson; John G Matthews; Karl Yen
Journal:  Thorax       Date:  2015-05-22       Impact factor: 9.139
View more
  14 in total

1.  Assessment of Lung Eosinophils In Situ Using Immunohistological Staining.

Authors:  Christopher D Nazaroff; William E LeSuer; Mia Y Masuda; Grace Pyon; Paige Lacy; Elizabeth A Jacobsen
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.

Authors:  Melanie C Dispenza; Bruce S Bochner
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 3.  Deciphering the role of eosinophils in solid organ transplantation.

Authors:  Oscar Okwudiri Onyema; Yizhan Guo; Atsushi Hata; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Am J Transplant       Date:  2019-11-18       Impact factor: 8.086

Review 4.  Contributions of Eosinophils to Human Health and Disease.

Authors:  Amy D Klion; Steven J Ackerman; Bruce S Bochner
Journal:  Annu Rev Pathol       Date:  2020-01-24       Impact factor: 23.472

5.  Genetic colocalization atlas points to common regulatory sites and genes for hematopoietic traits and hematopoietic contributions to disease phenotypes.

Authors:  Christopher S Thom; Benjamin F Voight
Journal:  BMC Med Genomics       Date:  2020-06-29       Impact factor: 3.063

6.  AllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paper.

Authors:  Eva Untersmayr; Heather J Bax; Christoph Bergmann; Rodolfo Bianchini; Wendy Cozen; Hannah J Gould; Karin Hartmann; Debra H Josephs; Francesca Levi-Schaffer; Manuel L Penichet; Liam O'Mahony; Aurelie Poli; Frank A Redegeld; Franziska Roth-Walter; Michelle C Turner; Luca Vangelista; Sophia N Karagiannis; Erika Jensen-Jarolim
Journal:  Allergy       Date:  2019-03-06       Impact factor: 13.146

7.  Intravital imaging allows real-time characterization of tissue resident eosinophils.

Authors:  Andrew Chojnacki; Katarzyna Wojcik; Björn Petri; Gurpreet Aulakh; Elizabeth A Jacobsen; William E LeSuer; Pina Colarusso; Kamala D Patel
Journal:  Commun Biol       Date:  2019-05-13

8.  Single-site, five-year experience with human eosinophil isolation by density gradient centrifugation and CD16 immunomagnetic negative separation.

Authors:  Yun Cao; Sooncheon Shin; Daniela J Carroll; Jeremy A O'Sullivan; Bruce S Bochner
Journal:  BMC Res Notes       Date:  2020-04-10

9.  Comparison of IL-33 and IL-5 family mediated activation of human eosinophils.

Authors:  Evelyn L Angulo; Elizabeth M McKernan; Paul S Fichtinger; Sameer K Mathur
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

10.  Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma.

Authors:  Hyun Seung Lee; Da-Eun Park; Ji-Won Lee; Kyung Hee Sohn; Sang-Heon Cho; Heung-Woo Park
Journal:  Exp Mol Med       Date:  2020-01-20       Impact factor: 8.718
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.